Derma Sciences expands wound care offering with MedEfficiency acquisition
This article was originally published in Clinica
Executive Summary
MediHoney developer Derma Sciences is bolstering its wound care portfolio by agreeing to buy MedEfficiency, a specialist in diabetic foot ulcer treatment, for $14.5m.